Groowe Groowe / Newsroom / ACAD
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ACAD News

Acadia Pharmaceuticals Inc.

National Event Series "Parkinson's IQ + You" Arrives in Southern Nevada to Educate and Empower Parkinson's Disease Patients and Care Partners

prnewswire.com
ACAD

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

businesswire.com
ACAD

The Michael J. Fox Foundation Releases New Care Partner Guide to Support Families Living with Parkinson's

prnewswire.com
ACAD

Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research

prnewswire.com
TMO MRK BIO BIIB AMGN GILD REGN CRSP NTLA BMY ABBV AZN NVS PFE JNJ MRNA BNTX COR STEM ALGN EXAS MDLZ BHC CVS UNH CI CNC ELAN ZTS ISRG QRVO SWKS AVGO QCOM INTC MSFT GOOG AMZN IBM ORCL CRM ADBE NFLX DIS MCD SBUX KO PEP PG JPM BAC WFC C GS MS AXP V MA HD LOW COST TGT WMT BBY CMCSA VZ T XOM CVX SIRI UBER LYFT NVDA AMD MU AMAT LRCX ASML ADI TXN QGEN ILMN VRTX EDIT BEAM SRPT ACAD ALKS MDT SYK DHR GOOGL

BioNJ Elects Board Officers and Trustees

prnewswire.com
GMAB MRK AMTX JNJ ASND ACAD BMY PFE PTC NVS SNY CLDX

Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

businesswire.com
ACAD

Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union

businesswire.com
ACAD

Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders

globenewswire.com
MRK BMY AZN PFE NVS LLY GILD JNJ REGN ABBV NVO SNY VRTX AMGN BIIB INCY EXEL SRPT CRSP EDIT NTLA ALNY MRNA BNTX COHR IMUX INSM CYTK KODK LULU NVDA GOOG MSFT IBM AMAT ILMN ALKS ACAD MNKD TEVA BHC XBI IBB XLF XLK XLV JAZZ ACGL

Crystalys Therapeutics Expands Leadership Team with Appointment of Justin Thacker as Chief Financial Officer to Support Advancement of Phase 3 Trials of Dotinurad

prnewswire.com
ABBV ACAD ASTX CADL

The Michael J. Fox Foundation Launches 2026 "Parkinson's IQ + You" Event Series to Educate, Empower and Connect People and Families Living with Parkinson's Disease

prnewswire.com
ACAD